CClinicalTrials.gg
Status unknownNCT05201261Updated Jan 21, 2022

the Relationship Between Vertebral Body Length, Subarachnoid Space Width and Block Level

An observational study in Combined Spinal Epidurai Anesthesia and Lower Extremity Surgery, sponsored by Shengjing Hospital. Status unknown. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2022-01-21.

Sponsored by Shengjing Hospital · Observational

The sponsor has not verified this record recently (last verified Dec 2021), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
50
Ages
18 Years to 55 Years
Sex
All
01

Study summary

Spinal anesthesia technology has been widely used in various surgeries and multi-mode analgesia. Spinal ultrasound imaging has been proved to be a reliable tool for evaluating spinal parameters. Ultrasound-guided spinal puncture technology has also been skillfully applied in clinical practice. How to provide perfect nerve block effect for operation, provide good postoperative analgesia, and prevent unnecessary extensive block leading to other complications and related risks has always been the focus of anesthesiologists. Doses and the relationship between the anesthesia plane great individual differences, and previous research on the patient's own condition such as height, weight, 6 to the anesthesia plane have different results, the influence of clinical work often refer patients height adjustment of drug doses, this research attempts to evaluate ultrasound was used to assess spinal vertebral body in the plane of the length and width of subarachnoid and anesthesia.

02

Conditions studied

  • Combined Spinal Epidurai Anesthesia
  • Lower Extremity Surgery
03

In context

Lead sponsor

Shengjing Hospital is the lead sponsor of 124 studies on the registry; 57 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients undergoing elective surgery under spinal anesthesia. Inclusion criteria: (1) Elective lower extremity surgery; (3) ASA (American Society of Anesthesiologists) Grading: ⅰ - ⅲ.

Inclusion criteria

  • Patients undergoing elective lower limbs surgery
  • ASA: grade I to III

Exclusion criteria

Exclusion Criteria:

  • There are contraindications to spinal anesthesia
  • Allergic to local anesthetics
  • Patient refused
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
50 participants (estimated)
Patient registry
No

Groups and cohorts

  • Ultrasound-guided group

    Adult patients with American Society of Anesthesiologists physical status I/II/III scheduled to undergo elective Lower limb surgery under spinal anesthesia were considered for eligibility.

    Device: ltrasonic measure

Interventions

  • Deviceltrasonic measure

    In the right decubitus position, the spine was scanned with an ultrasonic convex array probe. Starting from the sacrum, the length of each vertebral body of the lumbar spine was measured on a para-midsagittal oblique view. The intervertebral space was located and the width of the subarachnoid space was measured on a midsagittal and transverse view.

06

What researchers measure

Primary outcomes

  1. The length of lumbar cone

    Ultrasound findings

    Time frame: 1year

  2. The width of subarachnoid space was measured by ultrasound

    Ultrasound findings

    Time frame: 1year

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 21, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05201261
Lead sponsor
Shengjing Hospital
Responsible party
Yanchao Yang (Principal investigator, Shengjing Hospital) — Principal investigator
First posted
Jan 21, 2022
Start date
Feb 2022 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Feb 2023 (estimated)
Last update
Jan 21, 2022

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion